Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo pharma news

Tag: aurobindo pharma news

Read all Latest developments, information and news on and about Aurobindo Pharmaceuticals - Page 8

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Aurobindo Pharma arm CuraTeQ Biologics completes successful Phase 1 Pharmacokinetics study of bone drug

Aurobindo Pharma Anakapalli facility gets 4 USFDA observations

Ruchika Sharma20 May 2023 12:31 PM IST

Hyderabad: Aurobindo Pharma has announced that the company has received four observations from the United States Food and Drug Administration (US FDA)...

Aurobindo Pharma arm gets marketing authorisation in UK for Zefylti

Aurobindo Pharma Director gets bail in Delhi Excise Policy Case

Farhat Nasim9 May 2023 4:14 PM IST

New Delhi: In a major respite to Aurobindo Pharma director P Sarath Chandra Reddy, the Delhi High Court has granted him bail in connection with the...

Aurobindo Pharma arm Apitoria Pharma appoints new CEO, Independent Director

Ruchika Sharma6 April 2023 11:00 AM IST

Telangana: Aurobindo Pharma has announced that Apitoria Pharma Private Limited, a wholly-owned subsidiary of the Company has appointed Dr. Sanjay...

Cancer drug: Aurobindo Pharma arm Eugia Pharma gets USFDA approval for Lenalidomide Capsules

Ruchika Sharma9 March 2023 1:15 PM IST

The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone.

Aurobindo Pharma Telangana facility gets VAI classification from USFDA

Ruchika Sharma15 Feb 2023 12:15 PM IST

New Delhi: Aurobindo Pharma has announced that the company has received Voluntary Action Indicated (VAI) from the US health regulator for its...

Aurobindo Pharma misses Q3 profit view on higher input costs

Ruchika Sharma12 Feb 2023 10:15 AM IST

The company derives about 90 percent of its revenue from exports, with US and Europe being two of its major markets.

Aurobindo Pharma subsidiary bags USFDA nod to manufacture, market Diclofenac Sodium Topical Solution

Ruchika Sharma8 Feb 2023 11:15 AM IST

Diclofenac Sodium Topical Solution USP, 2 % w/w is indicated for the treatment of the pain of osteoarthritis of the knee(s).

Aurobindo Pharma arm gets 2 USFDA observations for Unit I, III in Telangana

Ruchika Sharma19 Jan 2023 10:56 AM IST

Hyderabad: Aurobindo Pharma has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with 2 observations at the end of the...

Aurobindo Pharma arm gets USFDA nod for Azacitidine for Injection to treat myelodysplastic syndrome

Ruchika Sharma4 Jan 2023 11:07 AM IST

The product is indicated for the treatment of adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes.

Aurobindo Pharma JV Tergene gets CDSCO panel recommendation for 15-valent Pneumococcal Polysaccharide Conjugate Vaccine

Ruchika Sharma27 Dec 2022 3:42 PM IST

Hyderabad: Drugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization...

Aurobindo pharma join hands with IMT Hyderabad to offer Certified Leadership Program

Ruchika Sharma4 Dec 2022 4:30 PM IST

The company has shortlisted 35 candidates from over 150 mid-level managers from across functions following a coherent process that included –...

Aurobindo Pharma USA arm, Evive Biotech ink pact for commercialisation of Ryzneuta in US

Ruchika Sharma24 Nov 2022 11:15 AM IST

This important partnership builds on the comprehensive global development program of Ryzneuta, which includes 12 clinical trials and has enrolled over...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok